Schedule 13G ownership disclosure

PERNIX THERAPEUTICS HOLDINGS, INC.

Security class unavailable · CUSIP: 71426V108

Event date: 2016-03-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,739,079
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-16-000834
Form type
SC 13G
Filer
PERNIX THERAPEUTICS HOLDINGS, INC.
CIK
CIK 1024126
Filed
Mar 24, 2016
Reporting period
Mar 11, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub